Long-term Effectiveness and Safety of GH Replacement Therapy in Adults ≥60 Years: Data From NordiNet® IOS and ANSWER

Long-Term Safety of Growth Hormone in Adults With Growth Hormone Deficiency: Overview of 15 809 GH-Treated Patients

(2022) Gudmundur Johannsson et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Impact of Long-Term Growth Hormone Replacement Therapy on Metabolic and Cardiovascular Parameters in Adult Growth Hormone Deficiency: Comparison Between Adult and Elderly Patients

(2021) Elisabetta Scarano et al.   Frontiers in Endocrinology

AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY GUIDELINES FOR MANAGEMENT OF GROWTH HORMONE DEFICIENCY IN ADULTS AND PATIENTS TRANSITIONING FROM PEDIATRIC TO ADULT CARE

(2019) Kevin C. J. Yuen et al.   Endocrine Practice

Growth hormone replacement in adults: Real-world data from two large studies in US and Europe

(2019) Matthias M. Weber et al.   GROWTH HORMONE & IGF RESEARCH

Change in baseline characteristics over 20 years of adults with growth hormone (GH) deficiency on GH replacement therapy

(2019) Charlotte Höybye et al.   EUROPEAN JOURNAL OF ENDOCRINOLOGY

Application of non-HDL cholesterol for population-based cardiovascular risk stratification: results from the Multinational Cardiovascular Risk Consortium

(2019) Fabian J Brunner et al.   LANCET

Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel

(2017) Brian A. Ference et al.   EUROPEAN HEART JOURNAL

The effect of growth hormone (GH) replacement on blood glucose homeostasis in adult nondiabetic patients with GH deficiency: real-life data from the NordiNet®International Outcome Study

(2016) Matthias M. Weber et al.   CLINICAL ENDOCRINOLOGY

Impact of adult growth hormone deficiency on metabolic profile and cardiovascular risk [Review]

(2015) Lara Giovannini et al.   ENDOCRINE JOURNAL

Efficacy and safety of growth hormone replacement therapy in Japanese adults with growth hormone deficiency: a post-marketing observational study

(2013) Akira Shimatsu et al.   ENDOCRINE JOURNAL

Prospective Safety Surveillance of GH-Deficient Adults: Comparison of GH-Treated vs Untreated Patients

(2013) Mark L. Hartman et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Idiopathic Adult Growth Hormone Deficiency

(2013) Shlomo Melmed   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

The NordiNet® International Outcome Study and NovoNet® ANSWER Program®: rationale, design, and methodology of two international pharmacoepidemiological registry-based studies monitoring long-term clinical and safety outcomes of growth hormone therapy (Norditropin®)

(2013) Charlotte Höybye et al.   Clinical Epidemiology

Effects of growth hormone replacement within the KIMS survey on estimated cardiovascular risk and predictors of risk reduction in patients with growth hormone deficiency

(2011) Harald Jörn Schneider et al.   CLINICAL ENDOCRINOLOGY

GH replacement therapy in elderly GH-deficient patients: a systematic review

(2011) Nieke E Kokshoorn et al.   EUROPEAN JOURNAL OF ENDOCRINOLOGY

Evaluation and Treatment of Adult Growth Hormone Deficiency: An Endocrine Society Clinical Practice Guideline

(2011) Mark E. Molitch et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Major Lipids, Apolipoproteins, and Risk of Vascular Disease

(2009) The Emerging Risk Factors Collaboration*   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION